Corporate & Investor Presentation

Q3 FY21 financial results Diversified revenue by business & by geography OOH SaaS 12% $ in millions, except per share amounts Revenue Non-GAAP gross margin* Non-GAAP operating income* Non-GAAP EPS* * Refer to Non-GAAP reconciliations in the Appendix. 3Q21 $768.8 +0%, (3)% CC 59.6% (1) bps $241.8 +2% $1.30 +1% Masks & Other 40% Europe, Asia, and Other 35% 29 2021 ResMed | Corporate & Investor Presentation - updated 29APR21 OOH SaaS 12% Devices 48% Americas Sleep and Respiratory Care 53% ResMed

View entire presentation